Development and Application of Surrogate Endpoints in FDA's Drug Review Process

SUN Yu-xin, WEI Fen-fang, YANG Yue

Chinese Pharmaceutical Journal ›› 2017, Vol. 52 ›› Issue (5) : 414-419.

PDF(1335 KB)
PDF(1335 KB)
Chinese Pharmaceutical Journal ›› 2017, Vol. 52 ›› Issue (5) : 414-419. DOI: 10.11669/cpj.2017.05.016

Development and Application of Surrogate Endpoints in FDA's Drug Review Process

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 52(5): 414-419 https://doi.org/10.11669/cpj.2017.05.016

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1335 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉